Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
Vijayakumar Jawalagatti, Perumalraja Kirthika, Chamith Hewawaduge, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1926-1940
Open Access | Times Cited: 22

Showing 22 citing articles:

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 7
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
Adaptive Immunity Elicited by Vaccination

CABI eBooks (2025), pp. 110-156
Closed Access
Oral Delivery of mRNA Vaccine by Plant-Derived Extracellular Vesicle Carriers
Margherita Alba Carlotta Pomatto, Chiara Gai, Federica Negro, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1826-1826
Open Access | Times Cited: 12
Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
Vijayakumar Jawalagatti, Perumalraja Kirthika, John Hwa Lee
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
Ram Prasad Aganja, Chandran Sivasankar, Chamith Hewawaduge, et al.
Veterinary Research (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 17
Novel pro-and eukaryotic expression plasmid expressing omicron antigens delivered via Salmonella elicited MHC class I and II based protective immunity
Chandran Sivasankar, Chamith Hewawaduge, John Hwa Lee
Journal of Controlled Release (2023) Vol. 357, pp. 404-416
Closed Access | Times Cited: 8
Advancement of Engineered Bacteria for Orally Delivered Therapeutics
Peilin Guo, Shuang Wang, Hua Yue, et al.
Small (2023) Vol. 19, Iss. 48
Open Access | Times Cited: 8
Challenges and opportunities in the development of mucosal mRNA vaccines
Ameya R. Kirtane, Chaoyang Tang, Dylan Freitas, et al.
Current Opinion in Immunology (2023) Vol. 85, pp. 102388-102388
Closed Access | Times Cited: 8
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Menghao Yin, Hanruo Sun, Yanan Li, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 2
Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity
Ileana García-Silva, Dania O. Govea‐Alonso, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 207-222
Closed Access | Times Cited: 5
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 1
Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2
Karla Ivón Solís-Andrade, Omar González‐Ortega, Dania O. Govea‐Alonso, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1759-1759
Open Access | Times Cited: 8
Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster
Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, et al.
Microbes and Infection (2023) Vol. 25, Iss. 5, pp. 105101-105101
Open Access | Times Cited: 4
Oral non-viral gene delivery platforms for therapeutic applications
Asma Ghaemi, Masoume Vakili‐Azghandi, Khalil Abnous, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123198-123198
Closed Access | Times Cited: 4
Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12054-12054
Open Access | Times Cited: 2
Fasting before Intra-Gastric Dosing with Antigen Improves Intestinal Humoral Responses in Syrian Hamsters
Liam Wood, Jaime Hughes, Mark Trussell, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 572-572
Open Access
The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 769-780
Closed Access | Times Cited: 1
Live-Attenuated Salmonella-Based Oral Vaccine Candidates Expressing PCV2d Cap and Rep by Novel Expression Plasmids as a Vaccination Strategy for Mucosal and Systemic Immune Responses against PCV2d
Khristine Kaith S. Lloren, Chandran Sivasankar, John Hwa Lee
(2023)
Open Access | Times Cited: 1
Live-Attenuated Salmonella-Based Oral Vaccine Candidates Expressing PCV2d Cap and Rep by Novel Expression Plasmids as a Vaccination Strategy for Mucosal and Systemic Immune Responses against PCV2d
Khristine Kaith S. Lloren, John Hwa Lee
Vaccines (2023) Vol. 11, Iss. 12, pp. 1777-1777
Open Access | Times Cited: 1
Prevention

CABI eBooks (2023), pp. 151-169
Closed Access
Page 1

Scroll to top